glow ghk cu pen Adaptog Research | Introducing our 60mg Pens ✨ Now available and crafted to elevate your routine with a fresh, radiant boost. Ready to glow? Message us Glow Peptide | GHK-Cu, BPC-157,

Generally well-tolerated topically with decades of cosmetic use data Injectable use has less clinical safety data Copper overload is theoretically possible at high doses monitor in patients with Wilson's disease or other copper metabolism disorders The dramatic age-related decline in endogenous GHK-Cu levels (60% reduction by age 60) provides a biological rationale for supplementation Synergistic with vitamin C (supports collagen synthesis pathway) and retinoids Protect from excessive light exposure during storage Published Research Published Research & Clinical Data Peer-reviewed studies and clinical trial data related to GHK-Cu 3 manually curated All research below is conducted by independent institutions

However, most events were mild to moderate and clustered during the first weeks of dose escalation

Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, Harding JW

De Luca, A